BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...
LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today reported strong growth in 2022 in both its long-established Active Pharmaceutical Ingredient ...
POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...
The U.S. government has exercised a $12.3 million option with Marinus Pharmaceuticals to manufacture the active pharmaceutical ingredient (API) for the anti-seizure drug ganaxolone. The Department of ...
Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market for pharma companies.
Medylife Global FZE Leader Mr Salim Khan Medylife Global FZE is one of the fastest growing pharmaceutical company engaged in the business of Pharma API At Medylife Global FZE, we work every day to ...
The U.S. Food and Drug Administration has issued an establishment inspection report with a voluntary action indicated (VAI) classification to Natco Pharma’s active pharmaceutical ingredient (API) ...
BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results